Form 4: Merck Director Douglas M. Baker Jr. Reports Stock Transactions

Merck & Co., Inc. Director Douglas M. Baker Jr. reported transactions involving common stock and phantom stock units on May 29, 2026.

Summary

• Douglas M. Baker Jr., a Director at Merck & Co., Inc., has filed a Form 4 detailing changes in his beneficial ownership of company securities.
• The transactions occurred on May 29, 2026.
• Baker acquired 16,000 shares of Common Stock, held directly.
• He also acquired phantom stock units, which are to be settled in cash upon his termination of service.
• These phantom stock units, totaling 1,853.0997 units, have a value of $118.72 per unit and are linked to the Common Stock.
• Following these transactions, Baker beneficially owns 11,518.2084 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions without indicating significant buying or selling pressure that would strongly influence share price.

Positives

• Director Douglas M. Baker Jr. continues to hold a direct beneficial ownership of a significant number of Merck & Co., Inc. common shares.
• The acquisition of phantom stock units indicates continued alignment of management interests with long-term shareholder value, as these units are settled upon termination of service.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors seeking to understand insider sentiment and potential shifts in beneficial ownership.

Stakeholder Impact

• Shareholders: The filing provides transparency into a director's holdings, which can inform investor sentiment. The acquisition of phantom stock units suggests continued long-term commitment.
• Management: The transactions reflect standard compensation and ownership practices for company directors.

Key Dates

Keywords

Merck & Co., Inc., MRK, Form 4, Insider Trading, Beneficial Ownership, Director, Stock Transaction, Phantom Stock